APRINOIA Therapeutics Inc. (APRI)

APRINOIA Therapeutics was planning to go public, but the IPO was withdrawn on Oct 28, 2024.

IPO Price Range

$10.00 - $12.00

Shares Offered

500,000

Deal Size

$5.50M

APRINOIA Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	9.13	0.39	0.55
Revenue Growth	-	-28.36%	-
Gross Profit	9.13	0.39	0.55
Operating Income	-21.16	-28.26	-23.9
Net Income	-21.74	-28.23	-23.26

Fiscal Year	Current	FY 2022	FY 2021
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8.39	1.22	9.67
Total Debt	15.6	3.61	1.12
Net Cash (Debt)	-7.2	-2.39	8.56
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-12.88	-17.24	-24.3
Capital Expenditures	-1.26	-2.02	-0.5
Free Cash Flow	-14.14	-19.25	-24.8
Free Cash Flow Growth	-	-	-

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-231.67%	-7173.60%	-4344.91%
Pretax Margin	-237.34%	-7160.91%	-4229.27%
Profit Margin	-238.04%	-7165.23%	-4229.27%
FCF Margin	-154.81%	-4886.55%	-4509.09%